Literature DB >> 7441509

Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.

R D Olson, J S MacDonald, C J vanBoxtel, R C Boerth, R D Harbison, A E Slonim, R W Freeman, J A Oates.   

Abstract

Adriamycin (ADR) has been shown to produce free radicals in NADPH microsomal systems, to increase oxygen consumption of both hepatic microsomes and heart sarcosomes and to stimulate superoxide formation in cardiac, submitochondria particles. These reactive products could produce the cardiotoxicity of ADR by oxidizing various membrane structures, especially if the heart lacks sufficient protective reducing substances such as thiols. We examined 1) the effect of ADR on reduced glutathione (G-SH) levels in various tissues including heart, 2) the ability of the sulfhydryl (SH) donor, cysteamine, to alter soluble SH levels in heart tissue after ADR administration and 3) the effects of SH donors (cysteamine and N-acetyl cysteine and G-SH depletion by diethyl maleate on ADR-induced lethality in Swiss ICR-HA mice. A single injection of ADR (15 mg/kg i.p.) elicited a statistically significant fall in liver (P < .05), heart (P < .02) and erythrocyte (P < .01) G-SH levels. Treatment with cysteamine protected against the fall in soluble SH groups in heart tissue. Cysteamine (50 mg/kg, i.p., every 8 hr for 6 days) or N-acetylcysteine (100 mg/kg, i.p., 1 hr before and 7 hr after ADR) protected against ADR-induced lethality and decreased the appearance of microscopic myocardial lesions. When endogenous levels of G-SH were depleted by diethyl maleate (300 mg/kg i.p., every 8 hr for 4 days), ADR lethality was markedly potentiated. Diethyl maleate alone did not cause death. We conclude 1) ADR significantly lowers G-SH levels in erythrocytes, liver and heart tissue, 2) the lowering of cardiac SH groups by ADR can be prevented by cysteamine and 3) ADR toxicity can be potentiated by diethyl maleate, a G-SH depletor, and reduced by cysteamine or N-acetyl cysteine, SH donors. These results suggest that the G-SH system may be involved in the modulation of ADR-induced toxicity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441509

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  24 in total

1.  Significance of adaptation mechanisms in adriamycin induced congestive heart failure.

Authors:  P K Singal; N Siveski-Iliskovic; N Kaul; M Sahai
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

2.  Interaction of N-acetylcysteine and bleomycin on hyperbaric oxygen-induced lung damage in mice.

Authors:  D D Jamieson; D R Kerr; I Unsworth
Journal:  Lung       Date:  1987       Impact factor: 2.584

3.  Covalent protein binding of reactive adriamycin metabolites in rat liver and rat heart microsomes.

Authors:  M E Scheulen; H Kappus; A Nienhaus; C G Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

4.  Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy.

Authors:  N Iliskovic; B B Hasinoff; K L Malisza; T Li; I Danelisen; P K Singal
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

5.  Effects of 2-methyl-1,4-naphthoquinone (menadione) on myocardial contractility and cardiac sarcoplasmic reticulum Ca-ATPase.

Authors:  M Floreani; E Santi Soncin; F Carpenedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

6.  Copper deficient rat heart can compensate for doxorubicin-induced oxidant stress.

Authors:  J G Fischer; R L Tackett; E W Howerth; M A Johnson
Journal:  Biol Trace Elem Res       Date:  1993 May-Jun       Impact factor: 3.738

Review 7.  Doxorubicin cardiomyopathy.

Authors:  Kanu Chatterjee; Jianqing Zhang; Norman Honbo; Joel S Karliner
Journal:  Cardiology       Date:  2009-12-11       Impact factor: 1.869

8.  Naproxen aggravates doxorubicin-induced cardiomyopathy in rats.

Authors:  Rahila Ahmad Pathan; Bhulan Kumar Singh; K K Pillai; Kiran Dubey
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

9.  Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity.

Authors:  J A Jackson; J P Reeves; K H Muntz; D Kruk; R A Prough; J T Willerson; L M Buja
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

10.  Specific glutathione-SH inhibition of toxic effects of metabolized gentamicin on isolated guinea pig hair cells.

Authors:  H P Zenner; S Keiner; U Zimmermann
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.